首页 | 本学科首页   官方微博 | 高级检索  
检索        

癌症患者化疗辅助用药临床应用情况分析
引用本文:王伟兰,朱曼,郭代红,刘皈阳.癌症患者化疗辅助用药临床应用情况分析[J].中国药物应用与监测,2010,7(2):95-96.
作者姓名:王伟兰  朱曼  郭代红  刘皈阳
作者单位:解放军总医院药品保障中心,北京,100853
摘    要:目的:对我院肿瘤大楼化疗辅助药物的使用情况进行分析。方法:采用药库计算机信息管理系统收集2008年2-8月肿瘤大楼化疗辅助药物的有关数据,并进行统计分析。化疗辅助用药包括:保肝药、抑酸药、止吐药、升白细胞药、扶正祛邪中成药、生物免疫调节剂。结果:用药金额位居首位的是扶正祛邪中成药,为522.07万元,占用药总金额的31.16%,其他排序依次为保肝药占18.69%、止吐药占14.77%、生物免疫调节剂占14.45%、升白细胞药占10.62%、抑酸药占10.30%。还原型谷胱甘肽钠、多烯磷脂酰胆碱注射液、硫普罗宁片和奥美拉唑钠分别居DDDs前4位。结论:化疗辅助用药对提高机体免疫力,降低抗肿瘤药物的毒性,保证化疗顺利进行具有重要意义。

关 键 词:癌症  化疗  辅助用药  合理用药

Application analysis of adjuvant drugs in cancer chemotherapy
Authors:WANG Wei-lan  ZHU Man  GUO Dai-hong  LIU Gui-yang
Institution:(Pharmaceutical Care of PLA General Hospital,Beijing 100853,China)
Abstract:Objective:To investigate the utilization of adjuvant drugs in cancer chemotherapy in our hospital.Methods:The data retrieved from computer information management system of drug storeroom were analyzed statistically regarding the utilization of adjuvant drugs in chemotherapy from February to August 2008.Adjuvant drugs included hepatoprotectives,acid-suppressing drugs,antiemetics,interleukin drugs,Chinese patent drugs and bio-immunomodulator.Results:Chinese patent drugs for strengthening healthy energy to eliminate evils dominated the first in terms of consumption sum,which was 5.220 7 million yuan,consumption sum of Chinese patent drugs occupied 31.16% of the total consumption sum,followed by hepatoprotectives(18.69%),antiemetic(14.77%),bio-immunomodulator(14.45%),interleukin drug(10.62%) and acid-suppressing drugs(10.30%).Glutathione sodium for injection,polyene phosphatidylcholine for injection,tiopronin tablets,omeprazole sodium placed the top 4 in terms of DDDs.Conclusion:The adjuvant drugs in chemotherapy showed important signifi cance in improving the body immunity,decreasing the toxicity of the anti-cancer drugs.
Keywords:Cancer  Chemotherapy  Adjuvant drugs  Rational drug use
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号